EP Patent

EP3176159B1 — 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use

Assigned to Tersera Therapeutics LLC · Expires 2020-10-21 · 6y expired

What this patent protects

Patent listed against telotristat-etiprate.

Drugs covered by this patent

Patent Metadata

Patent number
EP3176159B1
Jurisdiction
EP
Classification
—
Expires
2020-10-21
Drug substance claim
No
Drug product claim
No
Assignee
Tersera Therapeutics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.